BMO Capital Maintains Market Perform on Stride, Lowers Price Target to $90
BMO Capital analyst Jeffrey Silber maintains Stride (NYSE:LRN) with a Market Perform and lowers the price target from $93 to $90.
Stocks · News reference
8-K filing — Stride, Inc. (LRN)
Filed: 2026-08-04 AccNo: 0001171843-26-005202 Size: 513 KB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus
Zacks highlights strong stock performance from its various rating systems and portfolios. Oportun Financial gained 31% after a Zacks Rank upgrade, Uranium Royalty advanced 67.6% following an Outperform recommendation, and Amgen returned 25.1% over 12 weeks. The article discusses economic conditions marked by geopolitical tensions, rising energy costs, and resilient but cooling labor markets, while showcasing the historical outperformance of Zacks' investment methodologies.
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Gainers Bloomin Brands (NASDAQ:BLMN) stock moved upwards by 22.0% to $10.88 during Wednesday's pre-market session. The company's market cap stands at $763.6 million. The company's, Q2 earnings came out
Stride shares are trading higher after the company reported better-than-expected Q4 financial results.